Key Takeaways
- • Buenavista Equity Partners has agreed to acquire a 71.2% stake in Tiryaq Medical Group, a Madrid-based healthcare company specializing in trauma care.
- • The transaction combines the purchase of existing shares with a capital increase intended to fund Tiryaq's expansion.
- • Tiryaq generates approximately €13 million in annual revenue and performs more than 5,000 surgical procedures a year.
- • Buenavista plans to grow Tiryaq across Spain both organically and through complementary acquisitions.
Summary
Buenavista Equity Partners has agreed to acquire a 71.2% stake in Tiryaq Medical Group, according to the publisher's summary of the original report. The Madrid-based healthcare company focuses on trauma care, minimally invasive surgery, cell therapy, spinal disorders and sports rehabilitation.
The transaction is structured as a combination of a secondary share purchase and a primary capital increase. The capital injection is intended to fund Tiryaq's expansion plans, distinguishing the deal from a pure change-of-control transaction.
Tiryaq generates around €13 million in annual revenue and performs more than 5,000 surgical procedures per year, indicating a established operating base in the Spanish private healthcare market. The source material does not disclose the purchase price, valuation multiples, or the selling shareholders.
Buenavista plans to pursue growth through two routes: organic expansion across Spain and complementary acquisitions. The detailed terms and closing timeline were not available in the source material reviewed.
The transaction is structured as a combination of a secondary share purchase and a primary capital increase. The capital injection is intended to fund Tiryaq's expansion plans, distinguishing the deal from a pure change-of-control transaction.
Tiryaq generates around €13 million in annual revenue and performs more than 5,000 surgical procedures per year, indicating a established operating base in the Spanish private healthcare market. The source material does not disclose the purchase price, valuation multiples, or the selling shareholders.
Buenavista plans to pursue growth through two routes: organic expansion across Spain and complementary acquisitions. The detailed terms and closing timeline were not available in the source material reviewed.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.